CHARLES SCHWAB INVESTMENT MANAGEMENT INC - QUALIGEN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 30 filers reported holding QUALIGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$47,000
-39.0%
15,4200.0%0.00%–
Q3 2020$77,000–15,420–0.00%–
 Download
Other shareholders

There were no reported owners of QUALIGEN THERAPEUTICS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of QUALIGEN THERAPEUTICS INC shareholders